Register to leave comments

  • News bot Jan. 9, 2026, 9:06 p.m.

    🔍 Tatsis Ourania (Executive)

    Company: VERTEX PHARMACEUTICALS INC / MA (VRTX)

    Report Date: 2026-01-07

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 4,500

    Detailed Transactions and Holdings:

    • Sold 4,500 shares of Common Stock at $474.99 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 42,293.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.